BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Acute Exacerbation of CRS Treatment Market Size, Share, Top Key Players, Growth, Trend and Forecast Till 2028

  The report provides details about market size, market restraints, drivers, challenges, growth opportunities, and top companies in the market.

  February 14, 2022

   · 

  7 min read
• Angiotensin Receptor Antagonists Market Analysis, Statistics, Revenue, Demand and Trend Analysis Research Report by 2028

  The global pharma & healthcare market report points out the key trends and developments taking place in this business space in the ongoing COVID-19 times.

  February 14, 2022

   · 

  7 min read
• Brachytherapy Afterloaders, Brachytherapy Seeds Market Size, Share, Growth, Analysis, Trend, and Forecast Research Report by 2028

  The report provides details about market size, market restraints, drivers, challenges, growth opportunities, and top companies in the market.

  February 14, 2022

   · 

  6 min read
• BioMidwest

  Clearside Biomedical’s Suprachoroidal Injection Platform Featured at the Angiogenesis, Exudation, and Degeneration 2022 Virtual Conference

  Clearside Biomedical, Inc. announced that multiple oral presentations on Clearside’s SCS injection platform featuring the SCS Microinjector® were given at the Bascom Palmer Eye Institute’s Angiogenesis, Exudation, and Degeneration 2002 Virtual Event held February 11-12, 2022.

  February 14, 2022

   · 

  5 min read
• Business

  Treace to Report Fourth Quarter and Full Year 2021 Financial Results on March 3, 2022

  Treace Medical Concepts, Inc., a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of Hallux Valgus, announced that it will release financial results for the fourth quarter and full year of 2021 after the close of trading on Thursday, March 3, 2022.

  February 14, 2022

   · 

  1 min read
• Business

  Aethlon Medical Announces Third Quarter 2021 Financial Results and Provides Corporate Update

  Aethlon Medical, Inc., a company developing medical technology to treat cancer and life-threatening infectious diseases, reported financial results for its third quarter ended December 31, 2021 and provided an update on recent developments.

  February 14, 2022

   · 

  11 min read
• Business

  Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2021 Results

  Medpace Holdings, Inc. announced financial results for the fourth quarter and full year ended December 31, 2021.

  February 14, 2022

   · 

  18 min read
• Biotech Bay

  UMC Health System Partners with Omnicell for Advanced Services Solutions to Streamline Medication Management and Enhance Clinical and Operational Outcomes

  Omnicell, Inc. announced that UMC Health System in Lubbock, Texas, has selected Omnicell’s comprehensive portfolio of Advanced Services solutions to support key pharmacy initiatives, including acute care, outpatient, retail, and 340B program strategies.

  February 14, 2022

   · 

  7 min read
• DBV Technologies to Present at the 11th Annual SVB Leerink Global Healthcare Conference

  DBV Technologies, a clinical-stage biopharmaceutical company, announced that Daniel Tassé, Chief Executive Officer, will present at the 11th Annual SVB Leerink Global Healthcare Conference on Friday, February 18th at 8:40 am ET.

  February 14, 2022

   · 

  1 min read
• Business

  Aytu BioPharma Announces Business and Pipeline Progress and Reports Second Quarter 2022 Financial Results

  Aytu BioPharma, Inc., a pharmaceutical company focused on developing and commercializing novel therapeutics, announced business and pipeline progress and reported financial results for its fiscal second quarter 2022 ended December 31, 2021.

  February 14, 2022

   · 

  12 min read